Evogene Ltd.
EVGN
$1.14
$0.000.00%
NASDAQ
| 12/31/2023 | 12/31/2023 | 12/31/2023 | 09/30/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -65.69% | -65.69% | -65.69% | 43.27% | 43.27% |
| Total Depreciation and Amortization | 0.30% | 0.30% | 0.30% | 2.16% | 2.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -208.87% | -208.87% | -208.87% | 105.43% | 105.43% |
| Change in Net Operating Assets | 138.71% | 138.71% | 138.71% | -248.39% | -248.39% |
| Cash from Operations | -37.25% | -37.25% | -37.25% | 15.20% | 15.20% |
| Capital Expenditure | 60.19% | 60.19% | 60.19% | -74.19% | -74.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -112.95% | -112.95% | -112.95% | 149.64% | 149.64% |
| Cash from Investing | -116.08% | -116.08% | -116.08% | 146.13% | 146.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.47% | -0.47% | -0.47% | -1.93% | -1.93% |
| Issuance of Common Stock | -99.44% | -99.44% | -99.44% | 11,764.71% | 11,764.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 134.48% | 134.48% | 134.48% | -100.55% | -100.55% |
| Cash from Financing | -101.88% | -101.88% | -101.88% | -25.35% | -25.35% |
| Foreign Exchange rate Adjustments | 453.57% | 453.57% | 453.57% | 87.44% | 87.44% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -192.41% | -192.41% | -192.41% | 356.52% | 356.52% |